196 related articles for article (PubMed ID: 24008298)
1. Control of HPV infection and related cancer through vaccination.
Tran NP; Hung CF; Roden R; Wu TC
Recent Results Cancer Res; 2014; 193():149-71. PubMed ID: 24008298
[TBL] [Abstract][Full Text] [Related]
2. Emerging human papillomavirus vaccines.
Ma B; Maraj B; Tran NP; Knoff J; Chen A; Alvarez RD; Hung CF; Wu TC
Expert Opin Emerg Drugs; 2012 Dec; 17(4):469-92. PubMed ID: 23163511
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for HPV-associated diseases.
Skolnik JM; Morrow MP
Mol Aspects Med; 2023 Dec; 94():101224. PubMed ID: 37931422
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenic human papillomavirus infection.
Schiffman M; Doorbar J; Wentzensen N; de Sanjosé S; Fakhry C; Monk BJ; Stanley MA; Franceschi S
Nat Rev Dis Primers; 2016 Dec; 2():16086. PubMed ID: 27905473
[TBL] [Abstract][Full Text] [Related]
5. HPV as a model for the development of prophylactic and therapeutic cancer vaccines.
Samara RN; Khleif SN
Curr Mol Med; 2009 Aug; 9(6):766-73. PubMed ID: 19689303
[TBL] [Abstract][Full Text] [Related]
6. Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology.
Campbell-Tofte J; Vrahatis A; Josefsen K; Mehlsen J; Winther K
Cell Mol Life Sci; 2019 Jan; 76(1):67-87. PubMed ID: 30324425
[TBL] [Abstract][Full Text] [Related]
7. [Current status of clinical trials of HPV therapeutic vaccines].
Wang MY; Cun YN
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1647-1654. PubMed ID: 37859385
[TBL] [Abstract][Full Text] [Related]
8. Advancements in mRNA Vaccines: A Promising Approach for Combating Human Papillomavirus-Related Cancers.
Iqbal L; Jehan M; Azam S
Cancer Control; 2024; 31():10732748241238629. PubMed ID: 38462683
[TBL] [Abstract][Full Text] [Related]
9. Tumor Immunity and Immunotherapy for HPV-Related Cancers.
Shamseddine AA; Burman B; Lee NY; Zamarin D; Riaz N
Cancer Discov; 2021 Aug; 11(8):1896-1912. PubMed ID: 33990345
[TBL] [Abstract][Full Text] [Related]
10. HPV entry into cells.
Aksoy P; Gottschalk EY; Meneses PI
Mutat Res Rev Mutat Res; 2017; 772():13-22. PubMed ID: 28528686
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of a cervical cancer vaccine.
Winters U; Roden R; Kitchener H; Stern P
Ther Clin Risk Manag; 2006 Sep; 2(3):259-69. PubMed ID: 18360601
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.
Kanodia S; Da Silva DM; Kast WM
Int J Cancer; 2008 Jan; 122(2):247-59. PubMed ID: 17973257
[TBL] [Abstract][Full Text] [Related]
13. T cell responses to viral infections - opportunities for Peptide vaccination.
Rosendahl Huber S; van Beek J; de Jonge J; Luytjes W; van Baarle D
Front Immunol; 2014; 5():171. PubMed ID: 24795718
[TBL] [Abstract][Full Text] [Related]
14. Microorganisms-derived antigens for preventive anti-cancer vaccines.
Buonaguro L; Cavalluzzo B; Mauriello A; Ragone C; Tornesello AL; Buonaguro FM; Tornesello ML; Tagliamonte M
Mol Aspects Med; 2023 Aug; 92():101192. PubMed ID: 37295175
[TBL] [Abstract][Full Text] [Related]
15. Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm.
Black S; Roach M; Rappuoli R
Vaccine; 2024 Mar; 42(8):1906-1909. PubMed ID: 38365488
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
17. HPV vaccines to prevent cervical cancer and genital warts: an update.
Dochez C; Bogers JJ; Verhelst R; Rees H
Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
[TBL] [Abstract][Full Text] [Related]
18. Next generation prophylactic human papillomavirus vaccines.
Schiller JT; Müller M
Lancet Oncol; 2015 May; 16(5):e217-25. PubMed ID: 25943066
[TBL] [Abstract][Full Text] [Related]
19. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
20. Present status of human papillomavirus vaccine development and implementation.
Herrero R; González P; Markowitz LE
Lancet Oncol; 2015 May; 16(5):e206-16. PubMed ID: 25943065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
